APPLICATION OF CELL‐OF‐ORIGIN SUBTYPES DETERMINED BY DIGITAL GENE EXPRESSION IN <scp>HIV</scp>‐RELATED DIFFUSE LARGE <scp>B</scp>‐CELL LYMPHOMAS
Maria João Baptista(Josep Carreras Leukaemia Research Institute), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Silvia Montoto(Queen Mary University of London), Armando López‐Guillermo(Barcelona Supercomputing Center), José Luís Mate(Universitat Autònoma de Barcelona), Blanca González‐Farré(Hospital Clínic de Barcelona), Miguel Alcoceba(Instituto de Investigación Biomédica de Salamanca), Maria Calaminici(Queen Mary University of London), Carlos García‐Ballesteros(Hospital Arnau de Vilanova), Eva González‐Barca(Institut Català d'Oncologia), Javier Briones(Hospital de Sant Pau), María José Terol(Hospital Clínico Universitario de Valencia), Antonio Martı́nez(Hospital Universitario de Móstoles), John G. Gribben(Queen Mary University of London), José M. Moraleda(Centro Regional de Hemodonación), Gustavo Tapia(Hospital Universitari Germans Trias i Pujol), Eugènia Abella(Hospital Del Mar), Juan‐Manuel Sancho(Hospital Universitari Germans Trias i Pujol), Mariano Provencio(Hospital Universitario Puerta de Hierro Majadahonda), Ana M Muñoz‐Mármol(Universitat Autònoma de Barcelona), F. Vall‐Llovera(Mútua Terrassa), Jordi Ribera(Josep Carreras Leukaemia Research Institute), Josep Muncunill(Universitat Autònoma de Barcelona), Pilar Miralles(Hospital General Universitario Gregorio Marañón), Pau Abrisqueta(Universitat Autònoma de Barcelona)
Cited by 0
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
|New England Journal of Medicine|2009|2.4k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k